Peer-reviewed articles
Older-onset hereditary breast and ovarian cancer (HBOC) syndrome patients and clinical value of germline multigene testing.
Uptake of Cascade Genetic Testing for Hereditary Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis
Fertility counseling for patients with hereditary breast and ovarian cancer syndrome
Disparities in Genetic Management of Breast and Ovarian Cancer Patients
At-risk cancer genetic syndrome identification (ARCAGEN-ID): Novel EHR integrated system to overcome disparities in identification and testing for cancer genetic syndromes
Impact of germline BRCA status on clinical outcomes of patients with HR+/HER2- early breast cancer.
A quality initiative in BRCA testing and timing of BRCA test prior to surgery in HER2- early stage breast cancer.
Real-world insights: Neoadjuvant KEYNOTE-522 regimen in triple-negative breast cancer patients with germline BRCA mutations
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status
Long-term oncologic outcome of breast-conserving surgery in breast cancer with BRCA 1/2 mutation (ON-BRCA II, KoREa-BSG 06).
Functional evaluation and clinical classification of BRCA2 variants
© 2025 Wolters Kluwer. All right reserved.